🚨 GEOFF COOK, CEO OF NOOM, JOINS THE POD!
We discuss the future of compounded GLP-1s, Noom's new microdosing program, why the Noom <>
$LLY deal fell apart, semaglutide API costs and possible tariff impact,
$HIMS core biz slowdown, and much more. Epic episode:
(link below)